BCR/Abl is an oncogene that is able to activate STAT5, which has been found to be increased in lung cancer cell lines, and was speculated to control the process of apoptosis through the up-regulation of the anti-apoptotic protein Bcl-xL [32], [33]. This evidence concerns the gene ABL1 and lung carcinoma.